Ground News

News from Express Pharma

Your destination for news from Express Pharma. See how Express Pharma’s media bias impacts the breaking news stories of today.

We’ve aggregated 285 of Express Pharma’s headlines and news stories over the past 3 months.

Ground News rates Express Pharma’s media bias as . . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Express Pharma’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Express Pharma

Where is Express Pharma located?Express Pharma's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Express Pharma News

Consulting

AWS Recognizes Agilisium as one of 13 Global Partners with both Generative AI and Life Sciences Consulting Competencies

100% Center coverage: 3 sources

LOS ANGELES, Feb. 12, 2025 /PRNewswire/ -- Agilisium, a leading data innovation partner for the Life Sciences industry, today announced that AWS has recognized it as one of 13 Global Partners with both Generative AI and Life Sciences Consulting competencies.…See the Story

United States · United States

Fragile X syndrome market to quadruple to $111.9 million in US and Germany by 2030, forecasts GlobalData - GlobalData

The fragile X syndrome (FXS) market across the US and Germany is projected to experience explosive growth, quadrupling from $28.7 million in 2025 to $111.9 million by 2030, a CAGR of 31.3% (2025-2030), driven by the anticipated launch of two high-priced targeted therapies for FXS in 2027, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Fragile X Syndrome: Opportunity Assessment and Forecast -Update,” a…See the Story

Tokyo, Japan · Tokyo

Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer’s Disease – DIR HONGKONG

TOKYO, Feb 14, 2025 – (JCN Newswire via SeaPRwire.com) – Oita University and Eisai Co., Ltd. (Eisai) announced today the development of a machine learning model to predict amyloid beta(1)(Aβ) accumulation in the brain, combining background data such as age, gender, smoking history and medical history, as well as general blood test and MMSE(2) items. This model is expected to enable primary care physicians to predict the accumulation of brain Aβ,…See the Story

News from Express Pharma

News from Express Pharma

Information about Express Pharma

Media Bias Ratings

Factuality

Ownership

Top Express Pharma News

AWS Recognizes Agilisium as one of 13 Global Partners with both Generative AI and Life Sciences Consulting Competencies

Fragile X syndrome market to quadruple to $111.9 million in US and Germany by 2030, forecasts GlobalData - GlobalData

Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer’s Disease – DIR HONGKONG

Similar News Topics

Topics Most Covered by Express Pharma

Sources Covering Similar Topics

Breaking News Topics Related to Express Pharma

News from Express Pharma

Information about Express Pharma

Media Bias Ratings

Factuality

Ownership

Breaking News Topics Related to Express Pharma

Top Express Pharma News

AWS Recognizes Agilisium as one of 13 Global Partners with both Generative AI and Life Sciences Consulting Competencies

Fragile X syndrome market to quadruple to $111.9 million in US and Germany by 2030, forecasts GlobalData - GlobalData

Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer’s Disease – DIR HONGKONG

Similar News Topics

Gaps in brand availability impact India’s pharmaceutical distribution: Vector Consulting Group report - Express Pharma

Lupin receives “A-” leadership rating from CDP for climate change and water security - Express Pharma

Sun Pharma amongst top 5% of global pharma companies in S&P Global Sustainability Yearbook 2025 - Express Pharma

Zydus and Beihai Biotech sign an exclusive licensing, supply and commercialization agreement for BEIZRAY (Albumin Solubilized Docetaxel Injection), a 505(B)(2) product for the US market - Passionate In Marketing

Mitigating Barriers to Cell and Gene Therapy Access

Rusan Pharma Chairman Dr Navin Saxena receives Russia’s ‘Order of Friendship’ and ‘Memorial Medal’ - Express Pharma

Glenmark Pharmaceuticals launches Latanoprost Ophthalmic Solution in the US - Express Pharma

Jubilant Biosys Limited Seals Deal with Pierre Fabre SA - The Times of Bengal